Kaiser Permanente Ventures invests in early to growth stage healthcare companies that strategically align with Kaiser Permanente's mission. Their focus is on innovations in digital health, health IT, medical devices, and services that enhance care delivery, patient outcomes, and operational efficiency.
Portfolio
6
Fund Size
$500M
Top Stage
Series A
Last 12 Mo
1
Team
BW
Brian Wojtowicz
Executive Director
DV
Daniel van den Bergh
Senior Investment Director
AS
Alexandra Shandiz
Principal
SJ
Samuel Jazzo
Senior Associate
JM
Jess Miao
Portfolio Analyst
Stage Distribution
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| SureCo | Series A | $23M | Sep 2025 |
| Incredible Health | Series B | $80M | Aug 2022 |
| Medically Home | Series D | $110M | Jan 2022 |
| Freenome | Series D | $300M | Dec 2021 |
| DexCare | Series A | $20M | Mar 2021 |
| Proteus Digital Health | Growth | $420M | — |
Top Co-Investors
Novartis Venture Fund2 shared
Base10 Partners1 shared
Andreessen Horowitz1 shared
Obvious Ventures1 shared
Health Velocity Capital1 shared
Perceptive Advisors1 shared
RA Capital Management1 shared
Bain Capital Life Sciences1 shared
Catalio Capital Management1 shared
Cormorant Asset Management1 shared
DCVC1 shared
GV (Google Ventures)1 shared
Janus Henderson Investors1 shared
Polaris Venture Partners1 shared
Sands Capital1 shared
Section 321 shared
T. Rowe Price Associates, Inc.1 shared
Eventide Asset Management1 shared
Logos Capital1 shared
Pura Vida Investments1 shared
Last updated: 1 March 2026